Clinical Trial Update: [18F]PT2385 PET/CT in Patients With Renal Cell Carcinoma [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating [18F]PT2385 PET/CT in renal cell carcinoma is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Clear Cell Renal Cell Carcinoma
• Renal Cell Carcinoma

Snippet

Sponsor: Orhan Kemal Oz | Conditions: Renal Cell Carcinoma, Clear Cell Renal Cell Carcinoma | Phase 1 | Status: RECRUITING